Variant <scp>ALK</scp>‐fusion positive anaplastic large cell lymphoma (<scp>ALCL</scp>): A population‐based paediatric study of the <scp>NHL‐BFM</scp> study group
Jette Luedersen(Universität Hamburg), Christine Damm‐Welk(Université Paris-Sud), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Reiner Siebert(Christian-Albrechts-Universität zu Kiel), Ilske Oschlies(Christian-Albrechts-Universität zu Kiel), Julia Richter(German Cancer Research Center), Jacqueline Nakel(Leibniz Institute of Virology (LIV)), Markéta Kalinová(Charles University), Udo zur Stadt(Universität Hamburg), Ingrid Simonitsch‐Klupp(Medical University of Vienna), Edita Kabíčková(University Hospital in Motol), Fabian Knörr, Andishe Attarbaschi(Cancer Research Institute of the Slovak Academy of Sciences), Minyue Qi(Beiersdorf (Germany)), Wilhelm Woessmann(Université Paris-Sud), Martin Zimmermann(Stichting Kinderoncologie Nederland), Katrin Scheinemann(University of Lucerne)
Cited by 10
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k